Sen. John Fetterman (D-PA) continues active Senate service into 2026, managing chronic health conditions stemming from his 2022 stroke, subsequent depression treatment, and a November 2025 ventricular fibrillation flare-up that led to a brief hospitalization but quick recovery. His January 2026 memoir "Unfettered" candidly addressed past struggles—including suicidal thoughts—yet reaffirmed commitment to his term through 2029, dismissing May 2025 reports of erratic behavior as politically motivated. Absent any verified recent health crises or resignation signals in the past 30 days, trader consensus at 89.5% "No" reflects low perceived risk of departure by year-end, bolstered by his bipartisan stances on Israel and mental health legislation amid partisan opinion calls for his exit. Late-breaking health events or scandals could shift odds.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedNEW
NEW
Dec 31, 2026
NEW
NEW
Dec 31, 2026
This market will resolve to “Yes” if John Fetterman ceases to be U.S. Senator from Pennsylvania for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.Sen. John Fetterman (D-PA) continues active Senate service into 2026, managing chronic health conditions stemming from his 2022 stroke, subsequent depression treatment, and a November 2025 ventricular fibrillation flare-up that led to a brief hospitalization but quick recovery. His January 2026 memoir "Unfettered" candidly addressed past struggles—including suicidal thoughts—yet reaffirmed commitment to his term through 2029, dismissing May 2025 reports of erratic behavior as politically motivated. Absent any verified recent health crises or resignation signals in the past 30 days, trader consensus at 89.5% "No" reflects low perceived risk of departure by year-end, bolstered by his bipartisan stances on Israel and mental health legislation amid partisan opinion calls for his exit. Late-breaking health events or scandals could shift odds.
This market will resolve to “Yes” if John Fetterman ceases to be U.S. Senator from Pennsylvania for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.
Market Opened: Nov 14, 2025, 7:17 PM ET
Volume
$0End Date
Dec 31, 2026Market Opened
Nov 14, 2025, 7:17 PM ETResolver
0x65070BE91...This market will resolve to “Yes” if John Fetterman ceases to be U.S. Senator from Pennsylvania for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.Sen. John Fetterman (D-PA) continues active Senate service into 2026, managing chronic health conditions stemming from his 2022 stroke, subsequent depression treatment, and a November 2025 ventricular fibrillation flare-up that led to a brief hospitalization but quick recovery. His January 2026 memoir "Unfettered" candidly addressed past struggles—including suicidal thoughts—yet reaffirmed commitment to his term through 2029, dismissing May 2025 reports of erratic behavior as politically motivated. Absent any verified recent health crises or resignation signals in the past 30 days, trader consensus at 89.5% "No" reflects low perceived risk of departure by year-end, bolstered by his bipartisan stances on Israel and mental health legislation amid partisan opinion calls for his exit. Late-breaking health events or scandals could shift odds.
This market will resolve to “Yes” if John Fetterman ceases to be U.S. Senator from Pennsylvania for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.
Volume
$0End Date
Dec 31, 2026Market Opened
Nov 14, 2025, 7:17 PM ETResolver
0x65070BE91...Sen. John Fetterman (D-PA) continues active Senate service into 2026, managing chronic health conditions stemming from his 2022 stroke, subsequent depression treatment, and a November 2025 ventricular fibrillation flare-up that led to a brief hospitalization but quick recovery. His January 2026 memoir "Unfettered" candidly addressed past struggles—including suicidal thoughts—yet reaffirmed commitment to his term through 2029, dismissing May 2025 reports of erratic behavior as politically motivated. Absent any verified recent health crises or resignation signals in the past 30 days, trader consensus at 89.5% "No" reflects low perceived risk of departure by year-end, bolstered by his bipartisan stances on Israel and mental health legislation amid partisan opinion calls for his exit. Late-breaking health events or scandals could shift odds.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions